SueWallSt Podcast Series Launches With Focus on Synopsys, Inc. (SNPS) Fraud Allegations

NEW YORK, NY / ACCESS Newswire / December 9, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Synopsys, Inc. (NASDAQ:SNPS) class action securities lawsuit A Class Action lawsuit was filed on behalf of Synopsys, Inc. investors who lost money as a result of alleged securities fraud between December 4, 2024 and September 9, […]

Your Guide to the Avantor, Inc. Lawsuit – A SueWallSt Podcast From Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / December 9, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Avantor, Inc. (NYSE:AVTR) class action securities lawsuit A Class Action lawsuit was filed on behalf of Avantor, Inc. investors who lost money as a result of alleged securities fraud between March 5, 2024 and October 28,

DexCom, Inc. (DXCM) Shareholders Get Answers in Latest SueWallSt Podcast

NEW YORK, NY / ACCESS Newswire / December 9, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding DexCom, Inc. (NASDAQ:DXCM) class action securities lawsuit A Class Action lawsuit was filed on behalf of DexCom, Inc. investors who lost money as a result of alleged securities fraud between January 8, 2024 and September 17,

Northern Graphite Grants Stock Options to Non-Executive Directors

Ottawa, Ontario–(Newsfile Corp. – December 9, 2025) – Northern Graphite Corporation (TSXV: NGC) (OTCQB: NGPHF) (FSE: 0NG) (XSTU: 0NG) (the “Company” or “Northern“) announces that, as part of the compensation of its Non-Executive Directors, it has granted a total of 2,860,000 stock options of the Company to Non-Executive Directors. The stock options will vest immediately,

Viscount Strengthens Gold-Copper Porphyry Model at Passiflora as Multiple Exploration Datasets Align

Next Phase to Include Shallow Drill Testing of USGS Breccia Pipes. Deep Drilling to Test the Strongest Portion of the Quantec MT Anomaly Vancouver, British Columbia–(Newsfile Corp. – December 9, 2025) – Viscount Mining Corp. (TSXV: VML) (OTCQB: VLMGF) (“Viscount” or the “Company”) is pleased to report the results of its 2025 multi-phase exploration program

ZenaTech Enters UK Market Closing Drone-as-a-Service Acquisition of Casado Design Ltd., Expanding to the Growing Telecom Tower Design and Infrastructure Sector

(NASDAQ:ZENA),(Boerse Frankfurt – Freiverkehr:49Q),(BMV:ZENA), VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology business solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces the acquisition of Casado Design Ltd., a survey and design

Greene Concepts Reflects on Its Journey of Renewal, Resilience, and National Growth with Be Water(TM)

MARION, NORTH CAROLINA / ACCESS Newswire / December 9, 2025 / Greene Concepts Inc. (OTCID:INKW), owner and operator of a 60,000-square-foot bottling facility in Marion, North Carolina, proudly reflects on its journey of renewal, resilience, and progress – from revitalizing a dormant bottling plant in 2018 to building a nationally recognized premium artesian spring water

From Research to Measurable Patient Outcomes, Bio-IT World Conference & Expo Celebrates 25th Annual Event Advancing the Future of Precision Medicine

Premier Global Gathering of Biopharma, Healthcare and IT Leaders Set for May 19-21, 2026 in Boston, With “Super Early Bird” Rates Available Until December 19, 2025 Bio-IT World Conference & Expo, the premier global event uniting more than 2,900 biopharma, biomedical research, healthcare, informatics and technology leaders, returns to Boston May 19-21, 2026 to celebrate

Lunai Bioworks Identifies Three Parkinson’s Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market

Lunai Bioworks (NASDAQ: LNAI), an AI-powered biotechnology company developing precision therapeutics, today announced the identification of three clinically relevant Parkinson's disease subtypes and prioritized drug targets that may accelerate proof-of-concept programs, derisk therapeutic development, and enable strategic co-development partnerships in a growing $13 billion market. https://mma.prnewswire.com/media/2841213/Picture1_Lunai_Bioworks_Precision_Parkinson__Disease_Subtypes_Via_Proteomic_and_Clinical_Integratio.jpg Using its proprietary Augusta Platform, Lunai Bioworks' wholly owned

Ajust Design Adds Strategic Communication Practice as Private Equity Firms Encounter Growing Competition for Capital

New practice integrates brand strategy with design execution for private capital firms Ajust Design today announced a strategic communication consulting practice for private equity and alternative investment firms. The new service addresses a shift in how PE firms approach brand positioning, moving from viewing it as a marketing afterthought to recognizing it as essential for

Scroll to Top